Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Mehta

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
The American Journal of Cardiology|March 6, 1992
Platelet-leukocyte-endothelial interactions in coronary artery diseaseJ L Mehta, F A Nicolini, W H Donnelly, et al.
Therapeutic Drug Monitoring|January 1, 1982
Optimal lidocaine dosing in patients with myocardial infarctionL M Lopez, J L Mehta, J D Robinson, et al.
Journal of Cardiovascular Pharmacology|May 1, 1992
Slow channel calcium blockers attenuate reoxygenation-mediated vascular contraction, but augment anoxia-mediated vascular contractionW H Haught, B C Yang, D L Lawson, et al.
Journal of the American College of Cardiology|March 1, 1991
Concurrent nitroglycerin administration decreases thrombolytic potential of tissue-type plasminogen activatorJ L Mehta, F A Nicolini, W W Nichols, et al.
The American Journal of Physiology|April 1, 1992
5-Hydroxytryptamine potentiates vasoconstrictor effect of endothelin-1B C Yang, W W Nichols, D L Lawson, et al.
British Journal of Pharmacology|January 1, 1997
Reperfusion injury in the endotoxin-treated rat heart: reevaluation of the role of nitric oxideB C Yang, L Y Chen, T G Saldeen, et al.
Circulation|June 7, 2000
Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosisK Ericson, T G Saldeen, O Lindquist, et al.
American Heart Journal|December 1, 1994
Failure of brief ischemic episodes to protect against myocardial dysfunction caused by ischemia and reperfusion in isolated rat heartsB C Yang, F A Nicolini, W W Nichols, et al.
Cardiovascular Research|April 1, 1991
Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosisF A Nicolini, W W Nichols, T G Saldeen, et al.
Journal of Cardiovascular Pharmacology|February 1, 1996
Recombinant lys-plasminogen given before, but not after, recombinant tissue-type plasminogen activator markedly improves coronary thrombolysis in dogs: relationship of thrombolytic efficacy with parameters of fibrinolysisL Y Chen, W W Nichols, T G Saldeen, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
The American Journal of Cardiology|March 6, 1992
Platelet-leukocyte-endothelial interactions in coronary artery diseaseJ L Mehta, F A Nicolini, W H Donnelly, et al.
Therapeutic Drug Monitoring|January 1, 1982
Optimal lidocaine dosing in patients with myocardial infarctionL M Lopez, J L Mehta, J D Robinson, et al.
Journal of Cardiovascular Pharmacology|May 1, 1992
Slow channel calcium blockers attenuate reoxygenation-mediated vascular contraction, but augment anoxia-mediated vascular contractionW H Haught, B C Yang, D L Lawson, et al.
Journal of the American College of Cardiology|March 1, 1991
Concurrent nitroglycerin administration decreases thrombolytic potential of tissue-type plasminogen activatorJ L Mehta, F A Nicolini, W W Nichols, et al.
The American Journal of Physiology|April 1, 1992
5-Hydroxytryptamine potentiates vasoconstrictor effect of endothelin-1B C Yang, W W Nichols, D L Lawson, et al.
British Journal of Pharmacology|January 1, 1997
Reperfusion injury in the endotoxin-treated rat heart: reevaluation of the role of nitric oxideB C Yang, L Y Chen, T G Saldeen, et al.
Circulation|June 7, 2000
Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosisK Ericson, T G Saldeen, O Lindquist, et al.
American Heart Journal|December 1, 1994
Failure of brief ischemic episodes to protect against myocardial dysfunction caused by ischemia and reperfusion in isolated rat heartsB C Yang, F A Nicolini, W W Nichols, et al.
Cardiovascular Research|April 1, 1991
Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosisF A Nicolini, W W Nichols, T G Saldeen, et al.
Journal of Cardiovascular Pharmacology|February 1, 1996
Recombinant lys-plasminogen given before, but not after, recombinant tissue-type plasminogen activator markedly improves coronary thrombolysis in dogs: relationship of thrombolytic efficacy with parameters of fibrinolysisL Y Chen, W W Nichols, T G Saldeen, et al.
Pageof 25